Systems Biology of Early Atopy (SUNBEAM)
Study Type/Phase: Observational
Atopic dermatitis, also known as eczema, is a major risk factor for food allergy and other allergic diseases. Currently, there is no reliable way to identify infants who will develop eczema. This study aims to identify prenatal and early life markers of high risk for food allergy and eczema. Biomarkers and risk factors that reliably identify a high-risk population could help implement current and new prevention strategies. In this study, clinical assessments will be conducted, questionnaire information will be collected, and biological and environmental samples will be obtained from the biological mother, biological father, and infant during the prenatal, perinatal, and postnatal periods.
Speak with your doctor to determine whether you meet the following criteria for participation in this study.
|Inclusion Criteria||Exclusion Criteria|
Lisa Packard, MD
The Division of Allergy, Immunology,
and Transplantation (DAIT)
The National Institute of Allergy and
Infectious Diseases (NIAID)
Michelle Backer, Clinical Research Program Lead
Elizabeth Hoang, Clinical Research Intern
For more information about this clinical trial, including trial status, eligibility and full trial listing, visit www.clinicaltrials.gov.